Skip to Main Content

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 6)

Conditions

Women's Health

Phase III

What is the purpose of this trial?

The study is performed to assess the efficacy and safety of Vilaprisan in subjects with uterine fibroids compared to standard of care

  • Ages
    18 years and older
  • Gender
    Female only
  • Trial with
    Bayer Healthcare Pharmaceuticals, Inc.
  • Start Date
    04/17/2018
  • End Date
    12/30/2018
Trial Image

For more information about this study, contact:

Kristin DeFrancesco

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    06/20/2018
  • Study HIC
    #2000021011